18 results · 27ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

COMPOSITE AND PORCELAIN POLISHING PASTE PROD. LINE

FDA 510(k)
FDA Class 2 ·Dental

Bosworth Fastray LC

FDA UDI
Harry J Bosworth Company·H66809214071·Fastray LC Standard Kit White

OXYBAND WOUND DRESSING

FDA 510(k)
FDA Unclassified ·Unknown

COALESCENT SURGICAL U-CLIP - OR OTHER TBD AND ACCESSORIES

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

AUTOSOFT 30

FDA Adverse Event
Malfunction ·UNOMEDICAL A/S·Product code FPA·July 25, 2024

VIRTUOSO II DR

FDA Adverse Event
Malfunction ·MEDTRONIC MED REL, INC.·Product code LWS·December 13, 2010

POWERED WHEELCHAIR

FDA Adverse Event
Malfunction ·INVACARE TAYLOR STREET·Product code ITI·January 17, 2013

SPECTRUM INFUSION PUMP

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE CORP·Product code FRN·February 6, 2014

PENTAX

FDA Adverse Event
Injury ·PENTAX·Product code EOQ·January 10, 2017

PENTAX

FDA Adverse Event
Injury ·PENTAX·Product code EOQ·January 10, 2017

PENTAX

FDA Adverse Event
Injury ·PENTAX·Product code EOQ·January 10, 2017

PENTAX

FDA Adverse Event
Injury ·PENTAX·Product code EOQ·January 10, 2017

PENTAX

FDA Adverse Event
Injury ·PENTAX·Product code EOQ·January 10, 2017

PENTAX

FDA Adverse Event
Injury ·PENTAX·Product code EOQ·January 10, 2017

SMR GLENOID BASEPLATE SMALL-R

FDA Adverse Event
Injury ·LIMACORPORATE S.P.A.·Product code KWS·December 6, 2022

PENTAX

FDA Adverse Event
Injury ·PENTAX·Product code EOQ·January 10, 2017

PENTAX

FDA Adverse Event
Injury ·PENTAX·Product code EOQ·January 10, 2017

The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.

FDA Enforcement
Class II ·Terminated·Welch Allyn Protocol, Inc·January 15, 2014